ÖzetAmaç: Otoimmün büllü hastalıklar, derideki spesifik antijenlere yönelik dokuda ya da kanda otoantikorların varlığı ile karakterize deri ve/veya mukoza tutulumu ile seyreden hastalıklar grubudur. Çalışmamızın amacı kliniğimize başvuran otoimmün büllü hastalıkların demografik ve klinik özelliklerini değerlendirmektir. Yöntem ve Gereçler: 2003-2011 yılları arasında kliniğimize başvuran klinik, histopatolojik ve immunopatolojik kriterlere dayanılarak otoimmün büllü hastalıklar tanısı konan hastalar retrospektif olarak değerlendirildi. Olgular; cinsiyetleri, yaşları, otoimmün büllü hastalık tanısı, lezyonların başlangıç zamanı ve lokalizasyonu, tutulum yaygınlığı, eşlik eden hastalıklar, hastaların aldığı tedavi, tedaviye yanıtları açısından değerlendirildi. Bulgular: Çalışmamıza toplam 85 hasta alındı. Hastaların 49'u kadın (%57,64), 36'sı erkekti (%42,36). Olguların 57'si (%67,05) pemfigus (P), 24'ü ise (%28,23) pemfigoid grubundaydı. Pemfigus vulgarisli olguların büllöz pemfigoidli olgulara oranı 3,16 olarak saptandı. Lezyonların başlangıç yaşları 22 ile 82 arasında değişiyordu ve kronisitesi 2 hafta ile 120 ay arasında değişiyordu. Olguların takipleri sırasında pemfigus vulgarisli bir olguya mide kanseri tanısı konuldu. Büllöz pemfigoidli üç olguda malinite eşlik ediyordu: Bir olgu kemik metastazlı opere meme karsinomu, bir olgu renal karsinoma ve bir olguda lenfoma mevcut idi. Bir olgu hariç tüm olgularımız klasik tedaviye yanıt verdi. Sonuç: Çalışmamızda en sık pemfigus vulgarise rastladık, ancak pemfigus/büllöz pemfigoid oranını ise daha önceki çalışmalara göre daha düşük saptadık. Ayrıca otoimmün büllü hastalıkların çeşitli hastalıklarla birlikte görülebilme ihtimali nedeniyle detaylı araştırılmaları gerektiğini vurgulamak istiyoruz. (Türk derm 2014; 48: 7-12) Anah tar Ke li me ler: Pemfigus vulgaris, büllöz pemfigoid, otoimmün büllü hastalık Sum maryBackground and Design: Autoimmune bullous dermatoses are a group of diseases characterized by the presence of autoantibodies in tissue or blood against specific cutaneous antigens. The aim of our study was to evaluate the demographical and clinical features of patients with autoimmune bullous diseases who applied to our clinic. Materials and Methods: We retrospectively analyzed the patients who were diagnosed with autoimmune bullous diseases according to clinical, histopathological and immunopathological criteria between the years 2003 and 2011. The subjects were evaluated according to their sex, age, the type of autoimmune bullous disease, the onset and localization of lesions, the extensity of involvement, associated diseases, the treatment they were given and the response to the treatment. Results: A total of 85 cases were included in our study. Fourty-nine (57.64%) patients were female, 36 (42.36%) were male. Fifty-seven cases (67.05%) belonged to pemphigus (P) group and 24 (28.23%) to pemphigoid. The ratio of patients with pemphigus vulgaris to the patients with pemphigoid was found to be 3.16. The age range of the onset of the symptoms was between 22 an...
Objective: Alopecia areata (AA) is a non-scarring disorder characterized by sudden loss of hairs. There is only one study that investigated the concepts of AA patients about their diseases. In this study self concepts about the causes and course of their disorder and their learning sources were asked to AA patients. Methods: 51 AA patients were enrolled to the study. The causes and the exacerbating factors of their disorders, how they have been directed to dermatology section, their concepts about the course of the disease and information sources were asked to the patients. Results: 30 of AA patients were male 21 were female. The ages of the patients varied between 15 and 63 years. While 49% of the patients accused stress as the cause, 18% was worried that it was a possible sign of cancer. 63% patients thought that stress played
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.